𝛼SK or Searchbullish
HSIE Results Daily: Dr Reddy’s Laboratories, Supreme Industries, Dalmia Bharat...
Dr Reddy’s Laboratories: EBITDA^ declined 11% YoY due to moderate sales growth of +4% YoY (as 10% QoQ decline in the US on lower gRevlimid sales was offset by +19% YoY growth in India
What is covered in the Full Insight:
- Dr Reddy’s Laboratories Overview
- Supreme Industries Performance and Outlook
- Dalmia Bharat Expansion Plans
- Gujarat Gas Strategic Focus
- Mastek's Growth Challenges and Opportunities
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 28-minute read)
Discussions
(Paid Plans Only)
- HSIE Results Daily: Dr Reddy’s Laboratories, Supreme Industries, Dalmia Bharat...23 Jan 2026
x